Grant: Discovery Grants Program - Individual
McMaster University
$39,000.00
Carboxyketose synthase catalysis and inhibition
FY 2024-25
Summary
Objectives:
Our objectives are to (a) explore a-carboxyketose synthase (aCKS) catalytic mechanisms using transition state (TS) analysis, (b) develop enzyme inhibitors as probes of TS stabilization, and as phosphate mimics, and (c) probe the effects of aCKS inhibition on bacterial physiology. New aCKS inhibitors that block bacterial growth will contribute to our understanding and control of antibiotic resistance - "a global crisis - a slow motion tsunami" (UN General Assembly).
aCKSs:
aCKSs synthesize 7 - 9 carbon monosaccharides essential to bacterial survival via an aldol-like reaction. They have been targeted for inhibition, mostly unsuccessfully, for over 40 years. This lack of success is due in large part to not understanding aCKSs' catalytic mechanisms. There is currently no mechanistic consensus, with multiple proposals directly contradicting each other. Inhibitor design so far has targeted tetrahedral intermediate (THI) formation, whereas THI breakdown appears to be the rate-limiting step, and thus the correct target.
Transition state (TS) analysis:
Enzymes catalyze reactions by binding to and stabilizing the TS up to 1020-fold more tightly than any other species. Small molecules that capture even a fraction of that binding energy by mimicking the TS geometry and charge are highly potent inhibitors.
We are in the process of determining the TS structure of NeuB, an aCKS, using kinetic isotope effects (KIEs), i.e., reaction rate changes upon isotopic substitution (e.g., 13C in place of 12C). TS analysis gives the structure of a TS that exists for 0.05 ps at a resolution equal to that of X-ray crystallography of stable compounds. It reveals which step is rate-limiting, the exact geometry and charge distribution, and which atoms are in motion in the TS.
Inhibitor design:
We have discovered that imine-based (C=N-X) inhibitors are TS mimics and the most potent aCKS inhibitors to date. This includes (i) a 10 nM DAHP synthase inhibitor, (ii) two inhibitors that inhibit bacterial growth, and appear to inhibit DAHP synthase in the cell, and (iii) a NeuB inhibitor whose non-covalent binding is effectively irreversible, i.e., Ki ~ 0. By focusing on mechanism, we have developed compounds that can be iteratively refined into even more powerful aCKS inhibitors.
Phosphates group are a challenge in inhibitor design since they are hydrolyzed in vivo, and their negative charges block cell entry. Our neutral phosphate-mimicking functional groups (C=N-X) help address the issues of cell permeability in inhibitors of phosphate-utilizing enzymes.
Specific Goals:
(a) We will solve the TS structures of NeuB, DAHP synthase, and KDO8P synthase.
(b) We will design and characterize new inhibitory motifs. As TS structures are solved, we will design new TS mimic inhibitors.
(c) We will probe bacterial growth inhibition to demonstrate whether our inhibitors are reaching the intended target in the cell, and whether they show synergy with other antibiotics.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2023-05515
Name nom
Berti, Paul
Department département
Chemistry and Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
39000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Carboxyketose synthase catalysis and inhibition
Keywords
enzyme mechanisms; enzymology; transition state analysis; rnxyinhibition; kinetic isotope effects; carboxyketose synthase; antibiotic resistance; antimicrobial compounds; reaction mechanisms
Application summary
Objectives:
Our objectives are to (a) explore a-carboxyketose synthase (aCKS) catalytic mechanisms using transition state (TS) analysis, (b) develop enzyme inhibitors as probes of TS stabilization, and as phosphate mimics, and (c) probe the effects of aCKS inhibition on bacterial physiology. New aCKS inhibitors that block bacterial growth will contribute to our understanding and control of antibiotic resistance - "a global crisis - a slow motion tsunami" (UN General Assembly).
aCKSs:
aCKSs synthesize 7 - 9 carbon monosaccharides essential to bacterial survival via an aldol-like reaction. They have been targeted for inhibition, mostly unsuccessfully, for over 40 years. This lack of success is due in large part to not understanding aCKSs' catalytic mechanisms. There is currently no mechanistic consensus, with multiple proposals directly contradicting each other. Inhibitor design so far has targeted tetrahedral intermediate (THI) formation, whereas THI breakdown appears to be the rate-limiting step, and thus the correct target.
Transition state (TS) analysis:
Enzymes catalyze reactions by binding to and stabilizing the TS up to 1020-fold more tightly than any other species. Small molecules that capture even a fraction of that binding energy by mimicking the TS geometry and charge are highly potent inhibitors.
We are in the process of determining the TS structure of NeuB, an aCKS, using kinetic isotope effects (KIEs), i.e., reaction rate changes upon isotopic substitution (e.g., 13C in place of 12C). TS analysis gives the structure of a TS that exists for 0.05 ps at a resolution equal to that of X-ray crystallography of stable compounds. It reveals which step is rate-limiting, the exact geometry and charge distribution, and which atoms are in motion in the TS.
Inhibitor design:
We have discovered that imine-based (C=N-X) inhibitors are TS mimics and the most potent aCKS inhibitors to date. This includes (i) a 10 nM DAHP synthase inhibitor, (ii) two inhibitors that inhibit bacterial growth, and appear to inhibit DAHP synthase in the cell, and (iii) a NeuB inhibitor whose non-covalent binding is effectively irreversible, i.e., Ki ~ 0. By focusing on mechanism, we have developed compounds that can be iteratively refined into even more powerful aCKS inhibitors.
Phosphates group are a challenge in inhibitor design since they are hydrolyzed in vivo, and their negative charges block cell entry. Our neutral phosphate-mimicking functional groups (C=N-X) help address the issues of cell permeability in inhibitors of phosphate-utilizing enzymes.
Specific Goals:
(a) We will solve the TS structures of NeuB, DAHP synthase, and KDO8P synthase.
(b) We will design and characterize new inhibitory motifs. As TS structures are solved, we will design new TS mimic inhibitors.
(c) We will probe bacterial growth inhibition to demonstrate whether our inhibitors are reaching the intended target in the cell, and whether they show synergy with other antibiotics.